Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05104476 · ClinicalTrials.gov registry record · Phase 2

A Study of Lu AF82422 in Participants With Multiple System Atrophy

A Phase 2 study of Multiple System Atrophy, sponsored by H. Lundbeck A/S.

Active
Registry status
Phase 2
Development phase
64
Enrollment target
19
Study locations

NCT05104476 is a Phase 2 study of Multiple System Atrophy that is active but no longer recruiting, run by H. Lundbeck A/S. The registered enrollment target is 64 participants, below the 266-participant average among 30 other Multiple System Atrophy trials with a reported enrollment target (76% lower). The trial reports 19 study locations across 12 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05104476, a Phase 2 study of Multiple System Atrophy, is active but no longer recruiting, sponsored by H. Lundbeck A/S.

ACTIVE NOT RECRUITING
Registry status
Phase 2
Development phase
64 participants
Enrollment target
19
Study locations

Study Summary

To find out the effect of Lu AF82422 on disease progression in participants with multiple system atrophy.

Conditions Studied

Multiple System Atrophy

Interventions

  • DRUG Placebo
  • DRUG Lu AF82422

Study Locations (19)

California

  • The Parkinsons and Movement Disorder Institute - Fountain Valley
  • University of California - San Diego - La Jolla
  • University of California, San Francisco Neurosciences Clinical Research Unit - San Francisco

Pennsylvania

  • Penn State Milton S. Hershey Medical Center - Penn State Hershey Neuroscience Institute (PSHNI) - Hershey
  • University of Pennsylvania - Philadelphia
  • University Of Pittsburgh - Pittsburgh

Florida

  • Parkinson's Disease And Movement Disorder Center Of Boca Raton - Boca Raton
  • University of Florida Norman Fixel Institute for Neurological Diseases - Gainesville

Illinois

  • Rush University Medical Center, Rush University Cancer Center - Chicago
  • Endeavor Health - Glenbrook Hospital - Glenview

New York

  • NYU Langone Health Medical Center - New York
  • Columbia University Medical Center - The Neurological Institute of New York - New York

Colorado

  • CenExel Rocky Mountain Clinical Research, LLC - Englewood

Massachusetts

  • Beth Israel Deaconess Medical Center - Boston

Minnesota

  • Mayo Clinic - Rochester

Trial Details

FieldValue
Enrollment Target 64 participants
Start Date 2021-11-16
Est. Completion 2028-03-07
Phase Phase 2

Sponsor

H. Lundbeck A/S

72 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05104476

The ClinicalTrials.gov registry entry for NCT05104476 describes a study currently listed as active not recruiting, categorized as Phase 2. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 266-participant average among 30 other Multiple System Atrophy trials with a reported enrollment target (76% lower). The listed sponsor is H. Lundbeck A/S, which has 72 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Multiple System Atrophy appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT05104476 reports 19 study locations spanning 12 distinct geographic areas - top geographies include California, Pennsylvania, Florida.

Frequently Asked Questions

What is clinical trial NCT05104476 about?

NCT05104476 is a clinical study titled "A Study of Lu AF82422 in Participants With Multiple System Atrophy". To find out the effect of Lu AF82422 on disease progression in participants with multiple system atrophy.

What is the current status of trial NCT05104476?

This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 64 participants. The study started on 2021-11-16. Estimated completion is 2028-03-07.

What conditions does trial NCT05104476 study?

This clinical trial studies the following conditions: Multiple System Atrophy.

What interventions are being tested in trial NCT05104476?

The interventions under investigation include: Placebo (DRUG), Lu AF82422 (DRUG).

Who is sponsoring clinical trial NCT05104476?

This trial is sponsored by H. Lundbeck A/S, which has 72 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05104476 being conducted?

This trial has 19 study locations across California, Colorado, Florida, Illinois, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Multiple System Atrophy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Multiple System Atrophy

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.